I'm not sure how " The PR seemed to indicate they

I'm not sure how " The PR seemed to indicate they can move forward without China".

Mr. Moscato continued, “On the international front, we are moving forward with our partners in Malaysia and China on the development of the Ii-Key-SARS-CoV-2 vaccine. Bintai Kinden is supporting our US development efforts in exchange for exclusive distribution rights in Malaysia and Southeast Asia. We have also initiated discussions with our Chinese partners on the technology transfer, GMP production, and regulatory filings with the NMPA for the Phase I, II and III clinical programs in China. This partnership in China will also enable us to explore the potential of the Ii-Key-SARS-CoV-2 vaccine as a universal booster.

Seems pretty integral. It's possible that Joe wanted to clear the holidays and try to get an additional boost out of a PR on the $5MM. Of course, it's possible there are still issues w setting up the Chinese company (maybe the Jack Ma saga has the Chinese banking regulators clamping down). Or maybe there's a bigger issue there. We will know something by Thursday, either by announcement or omission...